BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33865103)

  • 1. Generation of human induced pluripotent stem cell lines (UNIMGi003-A and UNIMGi004-A) from two Italian siblings affected by Unverricht-Lundborg disease.
    Lucchino V; Scaramuzzino L; Scalise S; Grillone K; Lo Conte M; Esposito C; Aguglia U; Ferlazzo E; Perrotti N; Malatesta P; Parrotta EI; Cuda G
    Stem Cell Res; 2021 May; 53():102329. PubMed ID: 33865103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights into the Genetic Profile of Two Siblings Affected by Unverricht-Lundborg Disease Using Patient-Derived hiPSCs.
    Lucchino V; Scaramuzzino L; Scalise S; Lo Conte M; Zannino C; Benedetto GL; Aguglia U; Ferlazzo E; Cuda G; Parrotta EI
    Cells; 2022 Nov; 11(21):. PubMed ID: 36359887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electroclinical presentation and genotype-phenotype relationships in patients with Unverricht-Lundborg disease carrying compound heterozygous CSTB point and indel mutations.
    Canafoglia L; Gennaro E; Capovilla G; Gobbi G; Boni A; Beccaria F; Viri M; Michelucci R; Agazzi P; Assereto S; Coviello DA; Di Stefano M; Rossi Sebastiano D; Franceschetti S; Zara F
    Epilepsia; 2012 Dec; 53(12):2120-7. PubMed ID: 23205931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unverricht-Lundborg disease.
    Crespel A; Ferlazzo E; Franceschetti S; Genton P; Gouider R; Kälviäinen R; Korja M; Lehtinen MK; Mervaala E; Simonato M; Vaarmann A
    Epileptic Disord; 2016 Sep; 18(S2):28-37. PubMed ID: 27582036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel c132-134del mutation in Unverricht-Lundborg disease and the review of literature of heterozygous compound patients.
    Assenza G; Benvenga A; Gennaro E; Tombini M; Campana C; Assenza F; Di Pino G; Di Lazzaro V
    Epilepsia; 2017 Feb; 58(2):e31-e35. PubMed ID: 27888502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic testing and the phenotype of Polish patients with Unverricht-Lundborg disease (EPM1) - A cohort study.
    Bosak M; Sułek A; Łukasik M; Żak A; Słowik A; Lasek-Bal A
    Epilepsy Behav; 2020 Nov; 112():107439. PubMed ID: 32920378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First Molecular Diagnosis of a Patient with Unverricht-Lundborg Disease in Korea.
    Kim KH; Song JS; Park CW; Ki CS; Heo K
    Yonsei Med J; 2018 Aug; 59(6):798-800. PubMed ID: 29978618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unverricht-Lundborg disease in a five-generation Arab family: instability of dodecamer repeats.
    Mazarib A; Xiong L; Neufeld MY; Birnbaum M; Korczyn AD; Pandolfo M; Berkovic SF
    Neurology; 2001 Sep; 57(6):1050-4. PubMed ID: 11571333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystatin B: mutation detection, alternative splicing and expression in progressive myclonus epilepsy of Unverricht-Lundborg type (EPM1) patients.
    Joensuu T; Kuronen M; Alakurtti K; Tegelberg S; Hakala P; Aalto A; Huopaniemi L; Aula N; Michellucci R; Eriksson K; Lehesjoki AE
    Eur J Hum Genet; 2007 Feb; 15(2):185-93. PubMed ID: 17003839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A shared haplotype indicates a founder event in Unverricht-Lundborg disease patients from Serbia.
    Kecmanović M; Ristić AJ; Ercegovac M; Keckarević-Marković M; Keckarević D; Sokić D; Romac S
    Int J Neurosci; 2014 Feb; 124(2):102-9. PubMed ID: 23883076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haplotype study of West European and North African Unverricht-Lundborg chromosomes: evidence for a few founder mutations.
    Moulard B; Genton P; Grid D; Jeanpierre M; Ouazzani R; Mrabet A; Morris M; LeGuern E; Dravet C; Mauguière F; Utermann B; Baldy-Moulinier M; Belaidi H; Bertran F; Biraben A; Ali Chérif A; Chkili T; Crespel A; Darcel F; Dulac O; Geny C; Humbert-Claude V; Kassiotis P; Buresi C; Malafosse A
    Hum Genet; 2002 Sep; 111(3):255-62. PubMed ID: 12215838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and molecular characterization of Unverricht-Lundborg disease among Egyptian patients.
    Hosny H; El Tamawy M; Gouider R; Lesca G; Abdel Naseer M; Kishk N; Abdel-Hamid MS; Ashmawi A
    Epilepsy Res; 2021 Oct; 176():106746. PubMed ID: 34474241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unverricht-Lundborg disease: homozygosity for a new splicing mutation in the cystatin B gene.
    Pinto E; Freitas J; Duarte AJ; Ribeiro I; Ribeiro D; Lima JL; Chaves J; Amaral O
    Epilepsy Res; 2012 Mar; 99(1-2):187-90. PubMed ID: 22154554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severer phenotype in Unverricht-Lundborg disease (EPM1) patients compound heterozygous for the dodecamer repeat expansion and the c.202C>T mutation in the CSTB gene.
    Koskenkorva P; Hyppönen J; Aikiä M; Mervaala E; Kiviranta T; Eriksson K; Lehesjoki AE; Vanninen R; Kälviäinen R
    Neurodegener Dis; 2011; 8(6):515-22. PubMed ID: 21757863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of a human induced pluripotent stem cell line (UEFi004-A) from a patient with progressive myoclonic epilepsy type 1 (EPM1).
    Singh S; Plotnikova L; Karvonen K; Ryytty S; Hyppönen J; Kälviäinen R; Hämäläinen RH
    Stem Cell Res; 2023 Dec; 73():103248. PubMed ID: 37951142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refining the phenotype of Unverricht-Lundborg disease (EPM1): a population-wide Finnish study.
    Hyppönen J; Äikiä M; Joensuu T; Julkunen P; Danner N; Koskenkorva P; Vanninen R; Lehesjoki AE; Mervaala E; Kälviäinen R
    Neurology; 2015 Apr; 84(15):1529-36. PubMed ID: 25770194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA deamination enables direct PCR amplification of the cystatin B (CSTB) gene-associated dodecamer repeat expansion in myoclonus epilepsy type Unverricht-Lundborg.
    Weinhaeusel A; Morris MA; Antonarakis SE; Haas OA
    Hum Mutat; 2003 Nov; 22(5):404-8. PubMed ID: 14517952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Roles of Cystatin B in the Brain and Pathophysiological Mechanisms of Progressive Myoclonic Epilepsy Type 1.
    Singh S; Hämäläinen RH
    Cells; 2024 Jan; 13(2):. PubMed ID: 38247861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FOunder effect in patients with Unverricht-Lundborg disease on reunion island.
    Moulard B; Darcel F; Mignard D; Jeanpierre M; Genton P; Cartault F; Yaouanq J; Roubertie A; Biraben A; Buresi C; Malafosse A
    Epilepsia; 2003 Oct; 44(10):1357-60. PubMed ID: 14510831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular background of EPM1-Unverricht-Lundborg disease.
    Joensuu T; Lehesjoki AE; Kopra O
    Epilepsia; 2008 Apr; 49(4):557-63. PubMed ID: 18028412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.